Investing Profile

Jan Garfinkle

Photo of Jan Garfinkle, Managing Director at Arboretum Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
180 CONNECTIONS
The Wharton School Network
59 CONNECTIONS
Procter & Gamble Network
18 CONNECTIONS
cb
Arboretum Ventures Managing Director
$10.0M - $15.0M
$10.0M
11
$250M
CompanyStageDateRound SizeTotal Raised
Koya Medical
Series BFeb 2022$26M
Series AJan 2021$11M
$37M
Francis Medical
Series BSep 2021$55M
$55M
RareCyte
Series GSep 2021$24M
$76M
Co-investors: Brian Daniels (5am Ventures), David Kabakoff (HealthQuest Capital), Robert Weisskoff (F-Prime Capital Partners)
BAROnova
Series CFeb 2013$27M
Series BOct 2008$7.5M
Series AJan 2006$6.5M
$78M
Co-investors: Kevin Lalande (Santé Ventures)
Uptake Medical
Series CMar 2012$40M
Series BJul 2010$18M
$58M
Co-investors: Eric Kim (Goodwater Capital)
NxThera
Series BOct 2011$22M
$22M
CardioMEMS
Series FOct 2009$22M
$22M
Managing Partner, Founder Arboretum Ventures2002 - Present
President Strategic Marketing Consultants1995 - 2002
Director of Marketing and Clinical Research Devices for Vascular Intervention/Guidant1990 - 1995
Product Manager/Sales Representative Advanced Cardiovascular Systems/Guidant1984 - 1990
Manufacturing Manager/Process Engineer Procter & Gamble1979 - 1982
The Wharton School Master of Business Administration - MBA
University of California, Berkeley BSE Bioengineering